MF Analyser

Motilal Oswal Nasdaq Q50 ETF

Fund basics

Launched29 Dec 2021 4.9 years of history
CategoryIndex FundsSEBI classification
Plan & optionRegular · code 149438
BenchmarkNIFTY 100 TRI used for alpha & beta below
NAV as on11 Nov 2026source AMFI

Computed from 1,200 published NAVs between 29 Dec 2021 and 11 Nov 2026 — 4.9 years of history. Nothing here is an estimate; it is arithmetic on what the fund actually printed.

How it has moved

Return over time (%)

Fund name 1M3M6M1Y3Y5Y7Y10YSince launch
Motilal Oswal Nasdaq Q50 ETF Regular -4.87-7.742.74 33.0430.64— ——12.49
NIFTY 100 TRI benchmark -6.50-6.491.68 -6.827.476.95 11.9911.5813.28
Index Funds category median · 196 funds ——— 4.148.848.29 —12.51—

Anything over a year is annualised (CAGR); shorter windows are absolute. The benchmark row is the index's own Total Return Index, as published by NSE, measured to 11 Nov 2026. The category row is the median Regular plan in Index Funds — the middle fund, not a ranking, and a median rather than an average so that one mis-stated scheme cannot move it. As on 11 Nov 2026.

Risk measures

Fund name Volatility Sharpe Sortino Beta Alpha Max fall
Motilal Oswal Nasdaq Q50 ETF Regular 18.27 1.32 2.78 0.28 24.91 -30.98
NIFTY 100 TRI benchmark 14.83 0.07 0.09 —— -37.92

Risk-free rate 6.5%. The benchmark row is the index's NSE Total Return Index. Beta and alpha need the index as a reference, so the benchmark's own row leaves them blank.

Risk

VolatilityDownside volatilitySharpeSortino
18.3%8.7%1.322.78

Risk-free rate 6.5%, roughly the 10-year government bond.

The worst it has been

Deepest fallTime to recoverToday, from its peak
-31.0%27 months-8.6%
0%-11%-22%-33%202220242026
How far below its own record high the fund sat, on every single day it has existed. Flat along the top means it was making new highs; every dip is a stretch where somebody who bought at the wrong moment was down.

A drawdown is the fall from a previous high to the low that followed it. It is the number that decides whether somebody stays invested — a fund can have an excellent ten-year return and still have been unbearable to hold in year four.

Every one-year period it has lived through

Best yearMedian yearWorst yearLosing years
72.5%17.8%-22.8%9%
Worst-22.8%Median17.8%Best72.5%now
The full spread of one-year outcomes, with the fund's actual last twelve months marked. It answers the question a single number cannot: is right now an ordinary year for this fund, or an unusual one?

Rolling returns ask a fairer question than a single five-year figure: not "what did it do from this one start date", but "what happened across every start date". A fund whose worst year is −45% is a different proposition from one whose worst is −8%, even if the averages match.

Calendar years

-21.1%202212.8%202325.2%202419.4%202533.5%2026MF Analyser
Each year on its own, January to December. Losing years hang below the line — averages hide them, and the years somebody actually had to sit through are the ones that decide whether they stayed.

What it actually holds

The real portfolio the AMC filed with AMFI, as on 30 Sep 2026. Nothing here is estimated — when a fund has no filing in our store the section simply does not appear. A fund is its holdings; the returns above are only what those holdings did.

Asset allocation

99.87%Foreign Securities
0.13%Cash & Equivalents

A fund's risk starts here — how much of it is even in the market — before any question of which stocks or which sectors. Cash is not idleness; it is the manager's choice not to be invested, and it shows up as a drag in a rising market and a cushion in a falling one.

Portfolio aggregates

—Large
—Mid
—Small
Unclassified 99.9%99.9%Unclassified 99.9%
AMFI's half-yearly ranking: 1–100 Large, 101–250 Mid, 251+ Small. The rest is debt, cash, foreign holdings or fund units, which AMFI does not rank.

Concentration

Number of stocks52
Top 5 stocks19.00%
Top 10 stocks32.37%
Top 20 stocks54.18%
Largest single holding5.43%
Largest sectorBiotechnology · 23.12%
Number of sectors32
Effective stocks43.2
Cash & equivalents0.13%

Counting positions overstates diversification. The effective-stocks figure is the honest count: a portfolio can hold seventy names and still have most of its money in twenty.

Sector allocation

Biotechnology — 23.1%Semiconductors — 9.4%Internet Services & Infrastructure — 6.3%Technology Hardware, Storage & Peripherals — 4.8%Application Software — 3.7%Broadline Retail — 3.3%Transaction & Payment Processing Services — 3.2%Other — 46.2%Biotechnology23.1%Semiconductors9.4%Internet Services & Infra…6.3%Technology Hardware, Stor…4.8%Application Software3.7%Broadline Retail3.3%Transaction & Payment Pro…3.2%Other46.2%
Where the equity money sits, by industry.

Largest holdings

Top 10 are 32.4% of the fund. A high number means a concentrated portfolio — fewer names doing more of the work, for better and for worse.

Moderna Inc 5.43%
Natera Inc 4.21%
Ebay Inc 3.33%
Revolution Medicines Inc 3.11%
Illumina Inc 2.92%
NETAPP INC 2.91%
Flex Ltd 2.87%
Credo Technology Group Holding Limited 2.58%
United Airlines Holdings Ord 2.54%
Okta Inc 2.47%
BIOGEN INC 2.36%
Kimberly-Clark Corp 2.29%

Disclosed holdings from the AMC's AMFI filing, largest first. A portfolio is filed monthly and shifts between filings — this is the most recent one loaded, not a live book.

What the manager did last month

Between the filing of 31 Aug 2026 and 30 Sep 2026. A position grows for two reasons — the manager bought more, or the price went up — and only the first is a decision. The share count is what separates them, because it moves only when somebody trades.

Bought₹0.3 cr shares added, valued at this filing
Sold₹10.2 cr shares reduced or exited
New positions9 stocks not held a month ago
Sold out of9 stocks fully exited
Price move of what it held -0.13% the market's doing, not the manager's

Swipe the table sideways for share counts, price change and values.

Stock Shares traded Change in shares Change in price Value of the trade₹ crore Position now₹ crore
New positiondid not hold this a month ago 8
Moderna Inc 5,165 entered — 9.5 9.5
Okta Inc 2,162 entered — 4.3 4.3
Roivant Sciences Limited 9,345 entered — 3.3 3.3
F5 Inc 733 entered — 3.1 3.1
Incyte Corp 2,623 entered — 3.1 3.1
Rivian Automotive Inc-A 18,682 entered — 2.7 2.7
ROYAL GOLD INC 1,096 entered — 2.5 2.5
Cerebras Systems Class A 1,452 entered — 2.5 2.5
Added tobought more shares than last month 2
GlobalFoundries Inc 558 +10.8% +8.0% 0.3 2.6
Super Micro Computer Inc 137 +1.6% +10.9% 0.1 3.4
Trimmedcut the share count, without selling out 8
Natera Inc 124 -6.2% +29.3% 0.5 7.4
Ebay Inc 417 -6.8% +3.1% 0.4 5.9
Cognizant Technology Solutions Corp 761 -11.6% -10.4% 0.4 3.2
NETAPP INC 205 -7.5% +14.2% 0.4 5.1
Illumina Inc 148 -7.0% +29.0% 0.4 5.1
Revolution Medicines Inc 176 -6.0% +0.6% 0.4 5.5
Flex Ltd 315 -6.2% +1.4% 0.3 5.0
United Airlines Holdings Ord 307 -6.8% +3.5% 0.3 4.5
Sold out ofheld last month, gone this month 8
First Solar Inc 1,494 exited — 2.9 —
United Therapeutics Corp 590 exited — 2.9 —
MACOM Technology Solutions Holdings Inc 1,061 exited — 2.7 —
FTAI Aviation Limited 1,426 exited — 2.6 —
MKS Inc 938 exited — 2.3 —
Akamai Technologies Inc 2,022 exited — 2.1 —
Sterling Infrastructure Inc 427 exited — 1.9 —
IREN Limited 4,969 exited — 1.8 —

Only stocks and fund units are listed. Treasury bills, repo and money-market lines roll over every month by design — they are larger in rupees than most equity trades and are not decisions, so they are summarised as cash above rather than listed as activity. Share counts and values are the fund house's own filing. What a position cost when it was first bought is in no monthly disclosure, so a value here is what the shares were worth at the later filing, not what was paid.

One caveat on the share count: a corporate action — a stock split, a bonus issue, a merger, or an ISIN change — also moves the number of shares without the manager trading, and a monthly disclosure does not flag it. A sudden clean multiple (a doubling, a halving) is more likely a split than a decision. Treat a single large, round jump as something to check against the stock's own corporate-action history rather than as the manager buying or selling.

How it compares in its category

Against the Index Funds Regular schemes with the highest three-year return. Same category, same plan — the only comparison that means anything. The list re-sorts itself as returns move; it is an ordering by one number, not a view on which fund anyone should hold.

Return window
Scheme Return Alpha Beta Volatility Sharpe Max fall
Motilal Oswal Nasdaq Q50 ETF Motilal Oswal Mutual Fund · this scheme 30.6% 24.9% 0.28 18.3% 1.32 -31.0%
HDFC Silver ETF HDFC Mutual Fund 35.1% 33.0% 0.01 45.6% 0.63 -53.4%
HDFC Gold ETF HDFC Mutual Fund 30.4% 22.0% 0.06 20.6% 1.16 -29.6%
SBI Gold ETF SBI Mutual Fund 30.1% 21.9% 0.06 20.7% 1.14 -29.5%
ICICI Prudential NASDAQ 100 Index Fund ICICI Prudential Mutual Fund 26.5% 22.3% 0.29 17.5% 1.15 -30.2%
Motilal Oswal S&P 500 Index Fund Motilal Oswal Mutual Fund 24.3% 18.4% 0.25 12.5% 1.43 -20.1%
ICICI Prudential Nifty Pharma Index Fund ICICI Prudential Mutual Fund 22.0% 13.0% 0.63 15.0% 1.03 -16.8%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Edelweiss Mutual Fund 21.4% 12.1% 0.50 11.3% 1.31 -16.7%
ICICI Prudential Nifty Auto Index Fund ICICI Prudential Mutual Fund 19.9% 8.0% 1.21 20.9% 0.64 -28.5%

Alpha and beta are against NIFTY 100 TRI. Max fall is the deepest peak-to-trough drop in each fund's own history, so a longer-running fund has had more chances to record a bad one. Click a column to sort. This is a sort, not a ranking, and nothing here is a recommendation.

What a Index Funds scheme is

Track an index, holding its constituents in its proportions.

No manager, no stock picking, and an expense ratio a fraction of an active fund's. Over long periods that fee gap alone beats a majority of active large-cap funds — which is the strongest argument index funds have.

Who it suits. Anybody who would rather have the market's return at the lowest cost than try to beat it.

How long money should stay. 5 years or more.

Compare this scheme with others →

Questions people ask

What is the NAV of Motilal Oswal Nasdaq Q50 ETF — —?

₹115.4466 as on 11 Nov 2026, from AMFI's daily NAV file. NAV is declared once each business day after markets close, so the figure here is the most recent one published.

What is the difference between the Direct and Regular plan of Motilal Oswal Nasdaq Q50 ETF?

They hold the identical portfolio, run by the same manager. A Regular plan pays a distributor commission out of the fund, inside its expense ratio — commonly 0.5% to 1.2% a year more than Direct. That difference is charged on the whole balance every year, so it compounds. As an illustration, not a forecast: ₹1,00,000 invested for ten years at 12% a year ends at about ₹3.11 lakh, but at 10.5% — a 1.5 percentage-point gap and nothing else changed — it ends at about ₹2.71 lakh, roughly ₹40,000 less. The longer you hold, the wider the gap. Direct is the same fund without the commission.

What does the option mean?

An IDCW option pays part of the fund's gains out to you, and the NAV falls by exactly what it pays. It is not extra return — it is your own money returned, taxed at your slab rate. That also means a return computed from NAV alone understates an IDCW scheme, which is why no CAGR is shown here for it.

What kind of scheme is this?

Track an index, holding its constituents in its proportions. No manager, no stock picking, and an expense ratio a fraction of an active fund's. Over long periods that fee gap alone beats a majority of active large-cap funds — which is the strongest argument index funds have.

How long should money stay in it?

Typically 5 years or more. Anybody who would rather have the market's return at the lowest cost than try to beat it.